Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

The document concludes that understanding consumer-brand relationships is key for marketing and that perceived quality helps national brands maintain higher prices than store brands.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

New findings suggest certain genes and microRNAs are crucial for wound healing, and innovative technologies like smart bandages and apps show promise in improving treatment.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Wheat polar lipid complex reduces hair loss and improves hair growth in women.

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

Children with darker skin tones can have specific skin conditions that need tailored treatments.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Many people in Saudi Arabia lack awareness of thyroid disease risk factors and symptoms, highlighting the need for better health education.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.